PATENT CLAIM ANALYSIS

Application Number: 16028228
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-12
Patent Classification: ["514", "252120"]

Abstract:
The present invention provides a composition and method for treating acute on chronical liver failure or a related disease. The method comprises administering to a subject a composition comprising trimetazidine hydrochloride (1-[2,3,4-trimethoxybenzyl] piperazine dihydrochloride) (Trimetazidine or TMZ) or a pharmaceutically acceptable salt thereof according to a dosage regimen.

Claim (Index 11):
The method according to  claim 1 , wherein the pharmaceutical composition reduces beta-oxidation in hepatocytes and reduces formation of ROS in the subject.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 95.0
- Lexical Diversity: 1.32558
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14891746', '15092533', '11602571', '14326075', '12713497']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7130991376616943
- 35 USC 102 Novelty (BERT): 0.5028331064992412
- Combined Prediction Score: 0.6920725345454489
- Mean Citation Score: 190.156372
- Max Citation Score: 196.69803
- Similarity Product: 120.75757623540758

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test